Herceptin Research Today is a free monthly online journal that collates and summarizes the latest research about Herceptin, including details on side-effects, breast cancer, treatment, therapy.

Volume 3 (2006), Issue 5 (May)

1. Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer.
   Nat Clin Pract Oncol, 3(5): 269-280. [Abstract] [Full-text]
2. Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.
   Breast, 15(2): 219-225. [Abstract] [Full-text]
3. Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).
   Ann Oncol, 17(6): 935-44. [Abstract] [Full-text]
4. Zoledronic Acid (Zometa) Enhances the Cytotoxic Effect of Gemcitabine and Fluvastatin: In vitro Isobologram Studies with Conventional and Nonconventional Cytotoxic Agents.
   Oncology, 70(2): 147-53. [Abstract] [Full-text]
5. Effects of HER2-binding affibody molecules on intracellular signaling pathways.
   Tumour Biol, 27(4): 201-10. [Abstract] [Full-text]
6. Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
   J Clin Oncol, 24(15): 2276-82. [Abstract] [Full-text]
7. Growth inhibition of breast cancer cell lines overexpressing Her2/neu by a novel internalized fully human Fab antibody fragment.
   Cancer Immunol Immunother, 55(9): 1091-9. [Abstract] [Full-text]
8. Preparation and in vivo evaluation of a novel stabilized linker for (211)At labeling of protein.
   Nucl Med Biol, 33(4): 469-80. [Abstract] [Full-text]
9. Targeting tyrosine kinases in cancer: the second wave.
   Science, 312(5777): 1175-8. [Abstract] [Full-text]

© 2004-2008 Herceptin Research Today. All Rights Reserved.